Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

ClinicalTrials.gov ID: NCT06568042

Public ClinicalTrials.gov record NCT06568042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. Participation may last up to 30 weeks including screening.

Study identification

NCT ID
NCT06568042
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 22, 2024 (Actual)
Primary completion
Jan 12, 2026 (Actual)
Completion
Apr 15, 2026 (Actual)
Last update posted
Jul 10, 2026

2024 – 2026

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
MD First Research - Chandler Chandler Arizona 85286 —
HOPE Research Institute Phoenix Arizona 85032 —
Neuro-Pain Medical Center Fresno California 93710 —
Alpine Clinical Research Center Boulder Colorado 80301 —
Accel Research Sites - St. Pete-Largo Clinical Research Unit Largo Florida 33777 —
Design Neuroscience Center Miami Lakes Florida 33016 —
Conquest Research - Orlando Orlando Florida 32832 —
Charter Research - Lady Lake The Villages Florida 32162 —
Encore Medical Research - Weston Weston Florida 33331 —
Conquest Research Winter Park Florida 32789 —
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265 —
Lucida Clinical Trials New Bedford Massachusetts 02740 —
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Mid Hudson Medical Research New Windsor New York 12553 —
University of Rochester Medical Center Rochester New York 14618 —
Asheville Neurology Specialists, PA Asheville North Carolina 28806 —
Center for Clinical Research Winston-Salem North Carolina 27103 —
Neurology Diagnostics, Inc. Dayton Ohio 45459 —
New Phase Research and Development Knoxville Tennessee 37909 —
Cedar Health Research Dallas Texas 75251 —
Biopharma Informatic, LLC Houston Texas 77043 —
Clinical Trial Network Houston Texas 77074 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06568042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06568042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →